Literature DB >> 16112448

A critical review of Quality-of-Life Scales for Psoriasis.

Victoria J Lewis1, Andrew Y Finlay.   

Abstract

Psoriasis can have a major impact on the lives of patients who have psoriasis and many different methods are described to measure this effect. This article describes four general health measures, six dermatology-specific measures, four psoriasis-specific measures, and four utility measure concepts that are used in psoriasis. For each of these, the extent of validation, including reliability of each measure and correlation with other measures, is described. The experience of use of each measure is summarized and key references listed. Advice is given concerning strategy for choosing which measures to use.

Entities:  

Mesh:

Year:  2005        PMID: 16112448     DOI: 10.1016/j.det.2005.05.016

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

Review 1.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

2.  Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.

Authors:  Esteban Dauden; Enrique Herrera; Lluis Puig; José Luis Sánchez-Carazo; Jaime Toribio; Ma Teresa Caloto; Gonzalo Nocea; Montse Roset; Nuria Lara
Journal:  Health Qual Life Outcomes       Date:  2012-05-24       Impact factor: 3.186

3.  Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].

Authors:  Jean-Paul Ortonne; Neil Shear; Stephen Shumack; Eric Henninger
Journal:  BMC Dermatol       Date:  2005-12-16

Review 4.  Measuring Patient Quality of Life Following Treatment for Alopecia.

Authors:  Kunlawat Thadanipon; Poonkiat Suchonwanit
Journal:  Patient Prefer Adherence       Date:  2021-07-16       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.